Arrow Acquisition, LLC
Records under this name other than the patents Arrow Acquisition, LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 10 patents it holds.
Back to Arrow Acquisition, LLC
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,321,001 | Asthma and Allergic Inflammation Modulators Formerly held Term ended Term ended Nov 26, 2025 · High confidence | Term ended | Term ended Nov 26, 2025 | High confidence |
| US 11,142,442 | System and method for dynamically controlling the stability of an industrial vehicle Lapsed on the fee record Ended Oct 12, 2025 · From the USPTO record | Lapsed on the fee record | Ended Oct 12, 2025 | From the USPTO record |
| US 7,223,761 | Salts and Polymorphs of a Potent Antidiabetic Compound Formerly held Term ended Term ended Oct 1, 2024 · High confidence | Term ended | Term ended Oct 1, 2024 | High confidence |
| US 6,988,866 | Fork lift attachment for multi-purpose bucket Term ended Term ended Jun 22, 2023 · From the USPTO record | Term ended | Term ended Jun 22, 2023 | From the USPTO record |
| US 7,132,438 | Benzimidazole Derivatives Formerly held Term ended Term ended Jan 1, 2023 · High confidence | Term ended | Term ended Jan 1, 2023 | High confidence |
| US 6,884,782 | Stat Modulators Formerly held Term ended Term ended Dec 21, 2022 · High confidence | Term ended | Term ended Dec 21, 2022 | High confidence |
| US 7,601,841 | Quinolinyl and Benzothiazolyl Modulators Formerly held Term ended Term ended Oct 30, 2022 · High confidence | Term ended | Term ended Oct 30, 2022 | High confidence |
| US 7,067,662 | CXCR3 Antagonists Formerly held Term ended Term ended Jul 28, 2022 · High confidence | Term ended | Term ended Jul 28, 2022 | High confidence |
| US 6,794,379 | CXCR3 Antagonists Formerly held Term ended Term ended Jul 10, 2022 · High confidence | Term ended | Term ended Jul 10, 2022 | High confidence |
| US 6,964,967 | Substituted Pyrido[2,3-d]pyrimidines and Methods for Their Use Formerly held Term ended Term ended May 17, 2022 · High confidence | Term ended | Term ended May 17, 2022 | High confidence |